Oriol Sibila

European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial

Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study

OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2

The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)

Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis

Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study

Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis

Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling

Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis